What is the McKesson Corporation stock price forecast?

McKesson Corporation is currently trading at $784.05. View real-time AI analysis on Alpha Lenz.

What is McKesson Corporation insider trading activity?

View the latest insider trading data for McKesson Corporation on Alpha Lenz.

What is McKesson Corporation's P/E ratio?

McKesson Corporation's P/E ratio is 30.3.

McKesson Corporation

NYSE · MCK

$784.05-3.14(-0.40%)Pre-market

Ask about McKesson Corporation's future dividend policy...

Alpha Chat Insight

“McKesson Corporation trades at a P/E of 30.3 (premium valuation) with modest ROE of -162.9%. 3Y revenue CAGR of 10.8% highlights clear growth momentum.”

Ask for details →

Company Overview

McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.

CEOMr. Brian S. Tyler Ph.D.

Websitehttps://www.mckesson.com

SectorHealthcare

IndustryMedical Distribution

Employees43,000

Company Statistics

FY 2025

Profile

$99.89BMarket Cap

$359.05BRevenue

0.00Shares Out

43,000Employees

Margins

3.71%Gross

1.56%EBITDA

1.34%Operating

1.21%Pre-Tax

0.97%Net

Valuation

30.32P/E

-48.16P/B

0.28EV/Sales

18.25EV/EBITDA

19.11P/FCF

Growth (CAGR)

10.80%Rev 3Yr

9.22%Rev 5Yr

22.92%Op Inc 3Yr

11.13%Op Inc 5Yr

39.33%Net Inc 3Yr

25.46%Net Inc 5Yr

Returns

4.88%ROA

-162.92%ROE

6.49%ROIC

Financial Health

$5.69BCash & Cash Equivalents

$71.14BNet Debt

-4535.66%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“McKesson Corporation trades at a P/E of 30.3 (premium valuation) with modest ROE of -162.9%. 3Y revenue CAGR of 10.8% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

McKesson Corporation (ticker: MCK) is a company listed on NYSE in the Healthcare sector (Medical Distribution). It has approximately 43,000 employees. Market cap is $99.9B.

The current price is $784.05 with a P/E ratio of 30.32x and P/B of -48.16x.

ROE is -162.92% and operating margin is 1.34%. Annual revenue is $359.1B.